Skip to main content
medmix AG logo

medmix AG — Investor Relations & Filings

Ticker · 2022 ISIN · CH1129677105 LEI · 529900PL4KLKJVMULW74 SW Manufacturing
Open in API
Filings indexed 12 across all filing types
Latest filing 2026-03-18 Environmental & Social …
Country CH Switzerland
Listing SW 2022

About medmix AG

https://www.medmix.swiss/

medmix AG is a global leader in high-precision delivery devices and fluid mixing technologies. The company develops and delivers innovative solutions for healthcare, consumer, and industrial end-markets. Its operations are structured into two segments. The Healthcare segment provides specialized devices for dental applications, drug delivery systems for pharmaceutical partners, and precise applicators for surgical procedures involving bone regeneration and tissue treatment. The Consumer & Industrial segment delivers hand-held mixing and dispensing systems for adhesives and sealants, as well as high-precision applicators for the beauty industry, including microbrushes for mascara and lip gloss.

Recent filings

Filing Released Lang Actions
TIME names medmix as one of "World's Best Companies for Sustainable Growth 2026"
Environmental & Social Information Classification · 95% confidence The document is a media release announcing that medmix AG has been recognized by TIME Magazine as one of the 'World's Best Companies for Sustainable Growth 2026'. It discusses the company's sustainability strategy and environmental performance metrics. Since it is a general corporate announcement regarding an award and sustainability recognition rather than a formal ESG report, a financial report, or a regulatory filing, it falls under the general regulatory/corporate announcement category.
2026-03-18 English
FY25 results: Resilient Performance with Strong Profit Gains in Challenging Markets
Earnings Release Classification · 95% confidence The document is a 'Media Release' announcing the 'Full-Year 2025 Results' for medmix. It provides key financial highlights, management commentary, and operational updates. While it contains significant financial data, it is structured as a press release (Earnings Release) rather than the full Annual Report itself, which is explicitly linked at the end of the document. Therefore, it fits the definition of an Earnings Release (ER). FY 2025
2026-02-26 English
medmix wins one of the largest new Beauty businesses in company history and strengthens position in key global beauty markets with facility extensions
Regulatory Filings Classification · 100% confidence The document is a media release from medmix AG announcing strategic business developments, specifically facility expansions in China and Brazil and a new major business deal. It does not contain financial statements, proxy materials, or regulatory filings, but rather serves as a corporate news announcement. Since it does not fit into specific categories like earnings releases (ER) or M&A (TAR), and is a general corporate announcement, it falls under the Regulatory Filings (RNS) category as a catch-all for miscellaneous corporate news.
2025-10-08 English
medmix announces strategic partnership with Gurit for sustainable solutions for industrial bonding applications
Regulatory Filings Classification · 100% confidence The document is a media release announcing a strategic partnership between medmix AG and Gurit. It does not report financial results, dividends, or regulatory filings, nor is it a report publication announcement. As it describes a corporate partnership/business development activity that does not fit into specific categories like M&A or capital updates, it falls under the general regulatory/corporate announcement category.
2025-09-11 English
H1 25 results: Increased profitability despite subdued revenues
Earnings Release Classification · 100% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and prominently features 'Half-Year 2025 Results' and 'HALF-YEAR 2025 HIGHLIGHTS'. It provides detailed financial figures (Revenue, Adj. EBITDA margin, FCF) and operational reviews for the first half of the year (H1 2025). This structure—a comprehensive financial review for a period shorter than a year—is characteristic of an Interim/Quarterly Report. Although it is presented as an 'Ad hoc announcement' and mentions the report is available for download, the content itself is the detailed financial narrative, not just a brief announcement of publication. Therefore, it classifies as an Interim / Quarterly Report (IR) rather than a Report Publication Announcement (RPA). H1 2025
2025-07-23 English
Robust performance in challenging market environment
Earnings Release Classification · 100% confidence The document is titled 'Ad hoc announcement pursuant to Art. 53 LR' and presents 'Full-Year 2024 Results' with detailed financial highlights, segment reviews, strategic updates, and outlook for 2025. This content strongly indicates a comprehensive release of annual financial performance data. Although it contains highlights, the depth of the financial review (Revenue, Adj. EBITDA margin, ONCF, segment breakdowns) suggests it is more than just a brief Earnings Release (ER). Furthermore, it explicitly mentions the 'Full-year 2024 results presentation' and provides a link to the 'medmix full-year report'. Since the text is extensive (13,791 chars) and provides the core results narrative, it is classified as the primary report for the period. Given the comprehensive nature covering the entire fiscal year, it aligns best with the Annual Report (10-K) definition, even if it is an ad-hoc release format common outside the US SEC filings. However, since the definitions provided do not include a specific 'Full Year Results Press Release' category, and it is a comprehensive annual summary, it is closest to the spirit of the 10-K, but the presence of a link to the 'full-year report' and the announcement of the AGM date suggests it might be an accompanying document or a detailed press release that substitutes for a 10-K in this context. Given the detailed financial figures and strategic review, it is a primary financial report. If a specific 'Annual Results Press Release' existed, that would be ideal. Comparing the options, it is too detailed for an ER (10) and too comprehensive for an RPA (27). Since it covers the full year, it is the closest analogue to the Annual Report (10-K) among the choices, representing the official yearly performance summary. FY 2024
2025-02-26 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.